Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation.

Pierrot-Deseilligny C, Rivaud-Péchoux S, Clerson P, de Paz R, Souberbielle JC.

Ther Adv Neurol Disord. 2012 Jul;5(4):187-98. doi: 10.1177/1756285612447090.

PMID:
22783368
[PubMed]
Free PMC Article
2.

Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis.

Simpson S Jr, Taylor B, Blizzard L, Ponsonby AL, Pittas F, Tremlett H, Dwyer T, Gies P, van der Mei I.

Ann Neurol. 2010 Aug;68(2):193-203. doi: 10.1002/ana.22043.

PMID:
20695012
[PubMed - indexed for MEDLINE]
3.

Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis.

Runia TF, Hop WC, de Rijke YB, Buljevac D, Hintzen RQ.

Neurology. 2012 Jul 17;79(3):261-6. doi: 10.1212/WNL.0b013e31825fdec7. Epub 2012 Jun 13.

PMID:
22700811
[PubMed - indexed for MEDLINE]
4.

A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis.

Soilu-Hänninen M, Laaksonen M, Laitinen I, Erälinna JP, Lilius EM, Mononen I.

J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):152-7. Epub 2007 Jun 19.

PMID:
17578859
[PubMed - indexed for MEDLINE]
5.

Effectiveness and safety of vitamin D in relation to bone health.

Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.

PMID:
18088161
[PubMed - indexed for MEDLINE]
Free Article
6.

A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis.

Burton JM, Kimball S, Vieth R, Bar-Or A, Dosch HM, Cheung R, Gagne D, D'Souza C, Ursell M, O'Connor P.

Neurology. 2010 Jun 8;74(23):1852-9. doi: 10.1212/WNL.0b013e3181e1cec2. Epub 2010 Apr 28. Erratum in: Neurology. 2010 Sep 14;75(11):1029. Dosage error in article text. Neurology. 2010 Aug 3;75(5):480.

PMID:
20427749
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis.

Mowry EM, Krupp LB, Milazzo M, Chabas D, Strober JB, Belman AL, McDonald JC, Oksenberg JR, Bacchetti P, Waubant E.

Ann Neurol. 2010 May;67(5):618-24. doi: 10.1002/ana.21972.

PMID:
20437559
[PubMed - indexed for MEDLINE]
8.

Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial.

Kampman MT, Steffensen LH, Mellgren SI, Jørgensen L.

Mult Scler. 2012 Aug;18(8):1144-51. doi: 10.1177/1352458511434607. Epub 2012 Feb 21.

PMID:
22354743
[PubMed - indexed for MEDLINE]
9.

Skeletal and hormonal responses to vitamin D supplementation during sunlight deprivation in Antarctic expeditioners.

Iuliano-Burns S, Ayton J, Hillam S, Jones G, King K, Macleod S, Seeman E.

Osteoporos Int. 2012 Oct;23(10):2461-7. doi: 10.1007/s00198-011-1858-9. Epub 2012 Jan 4.

PMID:
22215183
[PubMed - indexed for MEDLINE]
10.

The impact of routine vitamin supplementation on serum levels of 25 (OH) D3 among the general adult population and patients with chronic kidney disease.

Tareen N, Martins D, Zadshir A, Pan D, Norris KC.

Ethn Dis. 2005 Autumn;15(4 Suppl 5):S5-102-6.

PMID:
16315388
[PubMed - indexed for MEDLINE]
11.

Serum 25(OH)D response to vitamin D3 supplementation: A meta-regression analysis.

Shab-Bidar S, Bours S, Geusens PP, Kessels AG, van den Bergh JP.

Nutrition. 2014 Jan 10. pii: S0899-9007(14)00038-0. doi: 10.1016/j.nut.2013.12.020. [Epub ahead of print] Review.

PMID:
24993750
[PubMed - as supplied by publisher]
12.

Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.

Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C.

Nephrol Dial Transplant. 2008 Nov;23(11):3670-6. doi: 10.1093/ndt/gfn339. Epub 2008 Jun 24.

PMID:
18579534
[PubMed - indexed for MEDLINE]
Free Article
13.

Sunlight exposure or vitamin D supplementation for vitamin D-deficient non-western immigrants: a randomized clinical trial.

Wicherts IS, Boeke AJ, van der Meer IM, van Schoor NM, Knol DL, Lips P.

Osteoporos Int. 2011 Mar;22(3):873-82. doi: 10.1007/s00198-010-1343-x. Epub 2010 Aug 4.

PMID:
20683712
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Immunomodulatory effects of Vitamin D in multiple sclerosis.

Correale J, Ysrraelit MC, Gaitán MI.

Brain. 2009 May;132(Pt 5):1146-60. doi: 10.1093/brain/awp033. Epub 2009 Mar 24.

PMID:
19321461
[PubMed - indexed for MEDLINE]
Free Article
15.

High-dose oral vitamin D3 supplementation in rheumatology patients with severe vitamin D3 deficiency.

von Restorff C, Bischoff-Ferrari HA, Theiler R.

Bone. 2009 Oct;45(4):747-9. doi: 10.1016/j.bone.2009.06.012. Epub 2009 Jun 17.

PMID:
19539796
[PubMed - indexed for MEDLINE]
16.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
[PubMed - indexed for MEDLINE]
17.

Self-prescribed high-dose vitamin D3: effects on biochemical parameters in two men.

Kimball S, Vieth R.

Ann Clin Biochem. 2008 Jan;45(Pt 1):106-10. doi: 10.1258/acb.2007.007074.

PMID:
18275686
[PubMed - indexed for MEDLINE]
18.

Safety of vitamin D3 in adults with multiple sclerosis.

Kimball SM, Ursell MR, O'Connor P, Vieth R.

Am J Clin Nutr. 2007 Sep;86(3):645-51.

PMID:
17823429
[PubMed - indexed for MEDLINE]
Free Article
19.

Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis.

Hiremath GS, Cettomai D, Baynes M, Ratchford JN, Newsome S, Harrison D, Kerr D, Greenberg BM, Calabresi PA.

Mult Scler. 2009 Jun;15(6):735-40. doi: 10.1177/1352458509102844. Epub 2009 Apr 21.

PMID:
19383644
[PubMed - indexed for MEDLINE]
20.

Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.

Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C.

Nephron Clin Pract. 2008;110(1):c58-65. doi: 10.1159/000151534. Epub 2008 Aug 25.

PMID:
18724068
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk